{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:42:43Z","timestamp":1764996163256},"reference-count":35,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,9,15]]},"DOI":"10.2169\/internalmedicine.0613-17","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T18:24:41Z","timestamp":1524767081000},"page":"2669-2673","source":"Crossref","is-referenced-by-count":14,"title":["Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection"],"prefix":"10.2169","volume":"57","author":[{"given":"Kotaro","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kajiyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Takano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Mabuchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinpei","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Miyakawa","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci 56: 958-976, 2011.","DOI":"10.1007\/s10620-011-1611-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Manns MP, Rambusch EG. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 31: 39-42, 1999.","DOI":"10.1016\/S0168-8278(99)80372-9"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48: 169-176, 2008.","DOI":"10.1002\/hep.22322"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ohira H. Current status and issues of autoimmune hepatitis in Japan. Kanzo (Jpn Soc Hepatol) 56: 167-178, 2015 (in Japanese, Abstract in English).","DOI":"10.2957\/kanzo.56.167"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takikawa H. Recent status of drug-induced liver injury. Hepatol Res 39: 1-6, 2009.","DOI":"10.1111\/j.1872-034X.2008.00400.x"},{"key":"6","unstructured":"6. Bj\u00f6rnsson E, Talwalkar J, Treeprasertsuk S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 51: 2040-2048, 2010."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Reynolds TB, Peters RL, Yamada S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med 285: 813-820, 1971.","DOI":"10.1056\/NEJM197110072851501"},{"key":"8","unstructured":"8. Bourdi M, Gautier JC, Mircheva J, et al. Anti-liver microsomes autoantibodies and dihydralazine induced hepatitis: specificity of autoantibodies and inductive capacity of the drug. Mol Pharmacol 42: 280-285, 1992."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lewis JH. Drug-induced liver disease. Med Clin North Am 84: 1275-1311, 2000.","DOI":"10.1016\/S0025-7125(05)70287-X"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Bachmeyer C, Cadranel JF. Minocycline-induced lupus and autoimmune hepatitis: family autoimmune disorders as possible risk factors. Dermatology 205: 185-186, 2002.","DOI":"10.1159\/000063890"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Punthakee Z, Scully LJ, Guindi MM, et al. Liver fibrosis attributed to lipid lowering medications: two cases. J Intern Med 250: 249-254, 2001.","DOI":"10.1046\/j.1365-2796.2001.00848.x"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Graziadei IW, Obermoser GE, Sepp NT, et al. Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis. Lupus 12: 409-412, 2003.","DOI":"10.1191\/0961203303lu313cr"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pelli N, Setti M, Ceppa P, et al. Autoimmune hepatitis revealed by atorvastatin. Eur J Gastroenterol Hepatol 15: 921-924, 2003.","DOI":"10.1097\/00042737-200308000-00014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wolters LM, Van Buuren HR. Rosuvastatin associated hepatitis with autoimmune features. Eur J Gastroenterol Hepatol 17: 589-590, 2005.","DOI":"10.1097\/00042737-200505000-00019"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Okada M, Satoh T, Watanabe J, et al. Autoimmune hepatitis induced by pravastatin: two cases. Kanzo (Jpn Soc Hepatol) 46: 133-141, 2005 (in Japanese, Abstract in English).","DOI":"10.2957\/kanzo.46.133"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Alla V, Abraham J, Siddiqui J, et al. Autoimmune hepatitis triggered by statins. J Clin Gastroenterol 40: 757-761, 2006.","DOI":"10.1097\/00004836-200609000-00018"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Castiella A, Fernandez J, Zapata E. Autoimmune hepatitis after treatment with fluvastatin. Liver Int 40: 592, 2007.","DOI":"10.1111\/j.1478-3231.2007.01498.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tajiri H, Masumoto A, Yada M, et al. A case of cirrhosis due to pravastatin-induced autoimmune hepatitis. Kanzo (Jpn Soc Hepatol) 51: 71-77, 2010 (in Japanese, Abstract in English).","DOI":"10.2957\/kanzo.51.71"},{"key":"19","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/hep.23834","volume":"52","author":"C Efe","year":"2010","unstructured":"19. Efe C, Purnak T, Ozaslan E, Wahlin S. Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor \u03b1 agents. Hepatology 52: 2246-2247, 2010.","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"20","unstructured":"20. Arai O, Omoto K, Notohara K, et al. A case of infliximab-related liver damage: Case report and literature review. Nihon Shokakibyo Gakkai Zasshi (J Jpn Soc Gostroenterol) 110: 104-111, 2013."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Black M, Rabin L, Schatz N, et al. Nitrofurantoin induced chronic active hepatitis. Ann Intern Med 92: 62-64, 1980.","DOI":"10.7326\/0003-4819-92-1-62"},{"key":"22","unstructured":"22. Pariente EA, Hamoud A, Goldfain D, et al. Hepatitis caused by clometacin (Duperan). Retrospective study of 30 cases. a model of autoimmune drug induced hepatitis? Gastroenterol Clin Biol 13: 769-774, 1989."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yeong TT, Lim KH, Goubet S, et al. Natural history and outcomes in drug-induced autoimmune hepatitis. Hepatol Res 46: E79-E88, 2016.","DOI":"10.1111\/hepr.12532"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. de Boer YS, Kosinski AS, Urban TJ, et al. Features of autoimmune hepatitis in patients with drug-induced liver injury. Clin Gastroenterol Hepatol 15: 103-112, 2017.","DOI":"10.1016\/j.cgh.2016.05.043"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Abe M, Furukawa S, Takayama S, et al. Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern Med 42: 48-52, 2003.","DOI":"10.2169\/internalmedicine.42.48"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Suzuki A, Brunt EM, Kleiner DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 54: 931-939, 2011.","DOI":"10.1002\/hep.24481"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tsutsui A, Harada K, Tsuneyama K, et al. Clinicopathological study of autoimmune hepatitis cases that were difficult to differentiate from drug-induced liver injury. Dig Dis 35: 506-514, 2017.","DOI":"10.1159\/000480139"},{"key":"28","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/0016-5085(92)90786-X","volume":"102","author":"M Shindo","year":"1992","unstructured":"28. Shindo M, Di Bisceglie AM, Hoofnagle JH. Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology 102: 1406-1408, 1992.","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Papo T, Marcellin P, Bernuau J, et al. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 116: 51-53, 1992.","DOI":"10.7326\/0003-4819-116-1-51"},{"key":"30","unstructured":"30. Takatori M, Iwabuchi S, Takatsuka K, et al. Huge portosystemic shunt associated with autoimmune hepatitis induced by interferon alpha 2b. J St. Marianna Univ 1: 25-30, 2010."},{"key":"31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/08916930108994106","volume":"33","author":"H Miyakawa","year":"2000","unstructured":"31. Miyakawa H, Kitazawa E, Kikuchi K, et al. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C. Autoimmunity 33: 23-32, 2000.","journal-title":"Autoimmunity","ISSN":"http:\/\/id.crossref.org\/issn\/0891-6934","issn-type":"print"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Robin MA, Le Roy M, Descatoire V, et al. Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. J Hepatol 26: 23-30, 1997.","DOI":"10.1016\/S0168-8278(97)82329-X"},{"key":"33","unstructured":"33. Lecoeur S, Andre C, Beaune PH. Tienilic acid induced autoimmune hepatitis : anti-liver and kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P450 2C9. Mol Pharmacol 50: 326-333, 1996."},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Manns MP, Obermayer-Straub P. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Hepatology 26: 1054-1066, 1997.","DOI":"10.1053\/jhep.1997.v26.pm0009328334"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Lapierre P, Lamarre A. Regulatory T cells in autoimmune and viral chronic hepatitis. J Immunol Res 2015: 479703, 2015.","DOI":"10.1155\/2015\/479703"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/18\/57_0613-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T00:59:35Z","timestamp":1537059575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/18\/57_0613-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,15]]},"references-count":35,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0613-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,15]]}}}